428.03

2.88% 11.99

Medpace Holdings Inc (MEDP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$416.04

Aprire:

$421.445

Volume 24 ore:

672.77K

Relative Volume:

2.35

Capitalizzazione di mercato:

$12.15B

Reddito:

$2.36B

Utile/perdita netta:

$433.01M

Rapporto P/E:

29.94

EPS:

14.2984

Flusso di cassa netto:

$676.77M

1 W Prestazione:

-21.03%

1M Prestazione:

-29.65%

6M Prestazione:

-8.54%

1 anno Prestazione:

+25.01%

Intervallo 1D:

$421.44

$442.41

Intervallo di 1 settimana:

$392.35

$547.07

Portata 52W:

$250.05

$628.92

Medpace Holdings Inc Stock (MEDP) Company Profile

Nome

Medpace Holdings Inc

Settore

Healthcare (1111)

Industria

Diagnostics & Research (53)

Telefono

(513) 579-9911

Indirizzo

5375 MEDPACE WAY, CINCINNATI, OH

Dipendente

6,200

Cinguettio

@WorkatMedpace

Prossima data di guadagno

2025-10-22

Ultimi documenti SEC

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MEDP Medpace Holdings Inc	428.03	11.81B	2.36B	433.01M	676.77M	14.30
TMO Thermo Fisher Scientific Inc	504.82	191.54B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	212.58	151.94B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	629.35	49.28B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	125.81	35.32B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	323.37	31.37B	3.17B	642.63M	539.81M	10.77

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-10	Aggiornamento	Robert W. Baird	Neutral → Outperform
2025-11-13	Iniziato	BMO Capital Markets	Market Perform
2025-10-02	Downgrade	Barclays	Equal Weight → Underweight
2025-09-03	Downgrade	Rothschild & Co Redburn	Buy → Neutral
2025-07-29	Downgrade	UBS	Neutral → Sell
2025-07-23	Downgrade	TD Cowen	Hold → Sell
2025-06-24	Iniziato	Barclays	Equal Weight
2025-04-22	Downgrade	William Blair	Outperform → Mkt Perform
2025-04-14	Downgrade	TD Cowen	Buy → Hold
2025-03-24	Iniziato	Leerink Partners	Market Perform
2024-10-23	Downgrade	Robert W. Baird	Outperform → Neutral
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-09-27	Downgrade	UBS	Buy → Neutral
2024-09-25	Downgrade	Jefferies	Buy → Hold
2024-08-01	Iniziato	Truist	Hold
2024-05-29	Iniziato	TD Cowen	Buy
2024-05-28	Iniziato	Mizuho	Buy
2024-04-23	Aggiornamento	Jefferies	Hold → Buy
2024-03-18	Iniziato	Deutsche Bank	Hold
2024-02-15	Aggiornamento	UBS	Neutral → Buy
2023-10-24	Aggiornamento	Robert W. Baird	Neutral → Outperform
2023-05-08	Aggiornamento	Guggenheim	Neutral → Buy
2022-10-27	Aggiornamento	UBS	Sell → Neutral
2022-09-07	Iniziato	UBS	Sell
2022-05-24	Iniziato	Guggenheim	Neutral
2021-08-05	Ripresa	Credit Suisse	Outperform
2020-10-02	Aggiornamento	Truist	Hold → Buy
2020-06-08	Aggiornamento	Robert W. Baird	Underperform → Neutral
2020-05-13	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-04-30	Aggiornamento	SunTrust	Sell → Hold
2020-04-20	Downgrade	Robert W. Baird	Neutral → Underperform
2020-03-17	Downgrade	SunTrust	Hold → Sell
2020-01-27	Downgrade	SunTrust	Buy → Hold
2018-10-31	Aggiornamento	SunTrust	Hold → Buy
2018-09-17	Iniziato	SunTrust	Hold
2018-07-31	Aggiornamento	William Blair	Mkt Perform → Outperform
2017-11-01	Downgrade	William Blair	Outperform → Mkt Perform
2017-09-29	Iniziato	Raymond James	Mkt Perform
2017-07-10	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

Mostra tutto

Medpace Holdings Inc Borsa (MEDP) Ultime notizie

Feb 13, 2026

Jefferies Upgrades Medpace to Buy From Hold, $560 Price Target - marketscreener.com

Feb 13, 2026

Prescott Group Capital Management L.L.C. Cuts Position in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 13, 2026

Medpace Holdings, Inc. (NASDAQ:MEDP) Just Reported, And Analysts Assigned A US$491 Price Target - simplywall.st

Feb 13, 2026

Medpace (MEDP) Q4 2025 Earnings Call Transcript - AOL.com

Feb 13, 2026

Feb 12, 2026

Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts - MSN

Feb 12, 2026

Assessing Medpace (MEDP) Valuation After A Sharp Share Price Pullback And Backlog Concerns - Yahoo Finance

Feb 12, 2026

What’s the fair value of Medpace Holdings Inc. stockJuly 2025 Action & Weekly Setup with ROI Potential - mfd.ru

Feb 12, 2026

Krilogy Financial LLC Purchases New Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 12, 2026

Feb 11, 2026

Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 11, 2026

Baird upgrades Medpace stock rating to Outperform on AI potential By Investing.com - Investing.com Australia

Feb 11, 2026

4 Analysts Have This To Say About Medpace Hldgs - Benzinga

Feb 11, 2026

Can Medpace Holdings Inc. continue delivering strong returns2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru

Feb 11, 2026

Baird upgrades Medpace stock rating to Outperform on AI potential - Investing.com

Feb 11, 2026

Deutsche Bank Adjusts Medpace Price Target to $480 From $600, Maintains Hold Rating - marketscreener.com

Feb 11, 2026

Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating - marketscreener.com

Feb 11, 2026

Medpace stock price target lowered to $460 by BMO Capital - Investing.com South Africa

Feb 11, 2026

Medpace (NASDAQ:MEDP) Given New $500.00 Price Target at Barclays - MarketBeat

Feb 11, 2026

Medpace stock price target lowered to $460 by BMO Capital By Investing.com - Investing.com India

Feb 11, 2026

Can Medpace Holdings Inc. lead its sector in growthJuly 2025 Snapshot & Weekly High Return Opportunities - mfd.ru

Feb 11, 2026

Leerink Partners Issues Pessimistic Forecast for Medpace (NASDAQ:MEDP) Stock Price - MarketBeat

Feb 11, 2026

Medpace (NASDAQ:MEDP) Price Target Lowered to $539.00 at Truist Financial - MarketBeat

Feb 11, 2026

Madison Asset Management LLC Sells 4,419 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 11, 2026

Candriam S.C.A. Decreases Stake in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 11, 2026

Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance By Investing.com - Investing.com South Africa

Feb 11, 2026

Medpace Q4 Earnings Beat Overshadowed by Cancellation Spike - AlphaStreet News

Feb 11, 2026

Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - Yahoo Finance

Feb 11, 2026

Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus

Feb 11, 2026

Feb 10, 2026

Medpace (MEDP) Stock Declines Significantly - GuruFocus

Feb 10, 2026

Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance - Investing.com Nigeria

Feb 10, 2026

Medpace Holdings’ Earnings Call Signals Growth Amid Volatility - TipRanks

Feb 10, 2026

Leerink Partners lowers Medpace stock price target on elevated cancellations By Investing.com - Investing.com South Africa

Feb 10, 2026

Medpace (MEDP) Sees Upgrade Despite Stock Decline - GuruFocus

Feb 10, 2026

Leerink Partners lowers Medpace stock price target on elevated cancellations - Investing.com

Feb 10, 2026